Treatment and Cure for TB
TB is a treatable disease and one that also has a vaccine. Though seldomly used in the US, BCG vaccine is given to prevent human TB with studies showing that the efficacy of the vaccine can last for 15 years in the body after injection (Kaufmann, Weiner & von Reyn, 2017). Treatment of active pulmonary TB is done using multi-drug therapy (usually four different types of drugs), where the administration will be done and monitored to see which drug works. The drug therapy usually lasts six to nine months, where completion of the therapy is considered as crucial, given the ability of the disease to resist antibiotics (Goutelle & Maire, 2017). Failure to adhere to the drug therapy as stipulated, the healthcare provider may be necessitated to be put the patient in observed therapy where they will personally monitor the administration of the drug to the patient. Some of the common drugs used in treating TB include ethambutol, Isoniazid, Pyrazinamide, and rifampin.
Is TB a Reportable Disease?
Reportable diseases can be termed as those diseases which are listed and stipulated by law to be reported to the relevant government healthcare agency failure to which legal actions can be taken. Many countries around the world consider TB as reportable. In the US, any suspected or confirmed TB cases are supposed to be reported no more than one official working day after the identification to the TB control station. This should be done irrespective of whether the test results are out or not. Reporting should also be done when a patient has been placed under the multi-drug therapy for either active pulmonary or extra-pulmonary TB.
Order this paper